Manu Jain – Grants — Northwestern Scholars

View Scopus Profile

Phone+1 312 503 4242
Emailm-jainnorthwesternedu

Research activity per year

If you made any changes in Pure these will be visible here soon.

15 Active
74 Finished

1 - 25 out of 74 results

Filter

Finished

Zasu IPA from 1/1/2021-05/31/2021
Jain, M.
Jesse Brown VA Medical Center
2/1/21 → 6/30/21
Project: Research project
Klug, Zasu Marie IPA
Jain, M.
Jesse Brown VA Medical Center
5/1/20 → 9/30/20
Project: Research project
Assessing the Transcriptional Response to Triple CFTR modulator Treatment of the Nasal Epithelium
Jain, M.
Cystic Fibrosis Foundation
1/1/20 → 12/31/21
Project: Research project
Cystic Fibrosis Lung Transplant Transition - Regional Dissemination Network
Jain, M.
Dartmouth College, Cystic Fibrosis Foundation
1/1/19 → 5/31/20
Project: Research project
TDN Protocol Review Committee Chair
Jain, M.
Cystic Fibrosis Foundation
1/1/19 → 12/31/20
Project: Research project
Multicenter study of patient-reported gastrointestinal symptoms in people with Cystic Fibrosis (GALAXY)
Jain, M. & Stein, A. C.
Seattle Children's, Cystic Fibrosis Foundation
12/1/18 → 11/30/19
Project: Research project
Prot #PTI-428-06: A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics, and Effect of PTI-428 in Subjects with Cystic Fibrosis
Jain, M.
MS Clinical Services, LLC, Proteostasis Therapeutics, Inc.
10/29/18 → 10/29/21
Project: Research project
Sexual and Reproductive Health in Adult Women with Cystic Fibrosis
Jain, M.
University of Pittsburgh, Cystic Fibrosis Foundation
10/1/18 → 9/30/20
Project: Research project
Prot #PTI-808-01: A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PTI-808 in Healthy Adult Subjects and in Adults with Cystic Fibrosis
Jain, M.
Chiltern International, Inc., Proteostasis Therapeutics, Inc.
8/2/18 → 8/2/21
Project: Research project
Prot #VX17-445-102: A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/M
Jain, M.
Greenphire, Inc., Vertex Pharmaceuticals Incorporated
6/5/18 → 6/5/21
Project: Research project
Optimization of Nasal Airway Cell Usage for CF Drug Discovery
Jain, M.
Rosalind Franklin University of Medicine and Science, Cystic Fibrosis Foundation
1/15/18 → 1/14/19
Project: Research project
Prot #VX17-661-901: Tezacaftor/Ivacaftor Combination Therapy Expanded Access Program for Patients 12 Years of Age and Older With Cystic Fibrosis
Jain, M.
Vertex Pharmaceuticals Incorporated
11/29/17 → 11/29/18
Project: Research project
Prot #PTI-801-01: A Multi-Center, Randomized, Placebo-Controlled, Phase 1, Two-Part Study Designed to Assess the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, an
Jain, M.
Rho, Inc., Proteostasis Therapeutics, Inc.
9/26/17 → 9/26/20
Project: Research project
Prot #VX16-445-001: A Phase 1/2 Study of VX-445 in Healthy Subjects and Subjects with Cystic Fibrosis
Jain, M.
Covance Inc., Vertex Pharmaceuticals Incorporated
7/3/17 → 7/3/20
Project: Research project
Prot #PTI-428-01: A Phase I/II, Multi-Center, Randomized, Placebo-Controlled, Study Designed to Assess the Safety, Tolerability, and Pharmacokinetics of PTI-428 in Subjects with Cystic Fibrosis
Jain, M.
Quintiles, Inc., Proteostasis Therapeutics, Inc.
6/28/17 → 6/28/20
Project: Research project
Award for a Physical Therapist
Jain, M.
Cystic Fibrosis Foundation
11/1/16 → 10/31/19
Project: Research project
Implementation of Outpatient Clinical Pharmacy Services: Award for a Pharmicst
Jain, M.
Cystic Fibrosis Foundation
11/1/16 → 10/31/19
Project: Research project
Prot #VX16-152-102: A Phase 2, Randomized, Double-blind, Controlled Study to Evaluate the Safety of VX-152 Combination Therapy in Adults With Cystic Fibrosis
Jain, M., Lam, A. P., Prickett, M. & Sala, M. A.
Covance Inc., Vertex Pharmaceuticals Incorporated
11/1/16 → 11/1/19
Project: Research project
Fellowship in support of Marc Sala: Program for Adult Care Excellence (PACE) Program
Jain, M. & Sala, M. A.
Cystic Fibrosis Foundation
7/1/16 → 6/30/19
Project: Research project
Developing Innovative Gastroenterology Specialty Training (DIGEST) Program
Stein, A. C. & Jain, M.
Cystic Fibrosis Foundation
6/1/16 → 5/31/19
Project: Research project
PRC Vice Chair
Jain, M.
Cystic Fibrosis Foundation Therapeutics, Inc.
5/1/16 → 12/31/18
Project: Research project
Prot #VX15-371-101: A Phase 2a, Randomized, Double-blind, Placebo-controlled, Incomplete Block, Crossover Study to Evaluate the Safety and Efficacy of VX-371 in Subjects Aged 12 Years or Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation
Jain, M., Lam, A. P. & Prickett, M.
Covance Inc., Vertex Pharmaceuticals Incorporated
4/14/16 → 4/14/19
Project: Research project
Prot #PQ-010-001: Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of QR-010 in Subjects with Homozygous ΔF508 Cystic Fibrosis
Jain, M., Lam, A. P. & Prickett, M.
INC Research, LLC, ProQR Therapeutics III B.V.
3/1/16 → 3/1/19
Project: Research project
Implementation of the Depression and Anxiety Guidelines: Award for A Mental Health Coordinator
Jain, M.
Cystic Fibrosis Foundation
1/1/16 → 12/31/19
Project: Research project
TEACH Trial: Testing the Effect of Adding Chronic Azithromycin to Inhaled Tobramycin. A randomized, placebo-controlled, double-blinded trial of azithromycin 500 mg thrice weekly in combination with inhaled tobramycin
Jain, M.
Seattle Children's, Cystic Fibrosis Foundation Therapeutics, Inc.
1/1/16 → 11/30/20
Project: Research project